MEDICOBIO
Research MEDICOBIO (MDB.WA) on Bullrun: market cap PLN 26.51M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMDB.WA
- ExchangeXNCO
- CountryPoland
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyPLN
- Market capPLN 26.51M
- Financial periodQ1 2026
- RevenuePLN 36.00K
- Net income-PLN 573.80K
- Free cash flow-PLN 202.81K
- Gross margin23.8%
Valuation Snapshot
latest market cap is PLN 26.51M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | PLN 119.90K | -PLN 2.23M | -PLN 983.56K | -61.4% | n/a | PLN 1.74K | PLN 2.47K | PLN 5.68M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-10 | PLN 26.51M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 PLN.
About MEDICOBIO
Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland. The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations. It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MEDICOBIO's market cap?
MEDICOBIO's market capitalization is PLN 26.51M.
What does MEDICOBIO do?
Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland. The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations. It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests. The company was formerly known as Inbook Spólka Akcyjna and changed its name to Medicofarma Biotech SA in February 2021.